MedPath

ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG

ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG

Pending
Register Number

89659

Prescription Type

Uso Hospitalario

Authorization Date

Jun 24, 2024

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89659
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

ERIBULINAActive
Quantity: 0,88 mg
Name: ERIBULINA

ATC CLASSIFICATION (3)

L01X
L01XX
L01XX41

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.